IMI – Clinical Management Guidelines Report

First report of IMI-1-producing colistin-resistant Enterobacter clinical isolate in Ireland, March 2013.

We report the first case in Ireland of an IMI-1 carbapenemase-producing Enterobacter asburiae, which was resistant to both colistin and fosfomycin. The circumstances under which this isolate was acquired were unclear. Several reports of IMI-producing Enterobacter spp. have emerged in recent years, and colistin resistance in Enterobacteriaceae is also increasingly reported. Laboratories should b...

Guidelines: Clinical practice guidelines for management of neuropathic pain

Neuropathic pain (NeuP) is challenging to diagnose and manage, despite ongoing improved understanding of the underlying mechanisms. Many patients do not respond satisfactorily to existing treatments. There are no published guidelines for diagnosis or management of NeuP in South Africa. A multidisciplinary expert panel critically reviewed available evidence to provide consensus recommendations f...

Agent - Based Management of Clinical Guidelines

This paper describes the main features of an agent-based application that provides medical services to users. The system contains agents that give information about the medical centres, departments and doctors of a city. These units coordinate their execution in order to offer to the user diverse functionalities such as searching for a medical centre, accessing the medical record or booking a v...

Clinical Guidelines for Acute Stroke Management

Efficient management of multi-version clinical guidelines

Clinical medicine and health-care developments in recent years testified a tremendous increase in the number of available guidelines, i.e., "best practices" encoding and standardizing care procedures for a given disease. Clinical guidelines are subject to continuous development and revision by committees of expert physicians and health authorities and, thus, multiple versions coexist as a conse...